HIGHLIGHTS
- who: Mary Glorieux and colleagues from the Laboratory of Experimental Radiotherapy, Department of Oncology, KU Leuven, University of Leuven have published the article: Effect of ATR Inhibition in RT Response of HPV-Negative and HPV-Positive Head and Neck Cancers, in the Journal: (JOURNAL) of 29/09/2017
- what: The authors will investigate the radiosensitizing effect of the ATR inhibitor AZD6738 both in_vitro and in_vivo models of HPV-positive and HPV-negative HNSCC. In contrast to their report, the authors demonstrate that the degree of radiosensitization of the ATR inhibitor AZD6738 differed between different cell . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.